Cargando…
Depressogenic medications and other risk factors for depression among Polish patients with epilepsy
PURPOSE: The aim of this study was to assess the prevalence of depression among patients with epilepsy and to establish the risk factors of depression in that group, with special focus on the use of potentially depressogenic medications. PATIENTS AND METHODS: We studied 289 consecutive patients who...
Autores principales: | Bosak, Magdalena, Turaj, Wojciech, Dudek, Dominika, Siwek, Marcin, Szczudlik, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599173/ https://www.ncbi.nlm.nih.gov/pubmed/26491329 http://dx.doi.org/10.2147/NDT.S91538 |
Ejemplares similares
-
Case Report: Vortioxetine in the Treatment of Depressive Symptoms in Patients With Epilepsy—Case Series
por: Siwek, Marcin, et al.
Publicado: (2022) -
Menstrual disorders and their determinants among women with epilepsy
por: Bosak, Magdalena, et al.
Publicado: (2018) -
COVID-19 among patients with epilepsy: Risk factors and course of the disease
por: Bosak, Magdalena, et al.
Publicado: (2021) -
Depressogenic effects of medications: a review
por: Celano, Christopher M., et al.
Publicado: (2011) -
Safety of switching from brand-name to generic levetiracetam in patients with epilepsy
por: Bosak, Magdalena, et al.
Publicado: (2017)